GIA632, Placebo to GIA632 clinical trials

A multicenter, randomized, double-blind, placebo-controlled, dose-ranging Phase IIb study to assess the efficacy and safety of GIA632 in adult participants with non-segmental vitiligo followed by an extension period

This study is testing a new medicine, GIA632, for adults with vitiligo. It aims to see how well it helps improve skin colour and if it's safe. Some people will get the new medicine, others will get a dummy medicine.